Clinical Trial Update: Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating danvatirsen as monotherapy followed by combination with venetoclax in relapsed/refractory myelodysplastic syndromes and acute …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Danvatirsen (danvatirsen)
• Venetoclax (venetoclax)

Snippet

Sponsor: Montefiore Medical Center | Conditions: AML/MDS, Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING